XML 22 R13.htm IDEA: XBRL DOCUMENT
v3.24.4

ACCRUED LIABILITIES | 9 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 30, 2024 | Dec. 31, 2023
Payables and Accruals [Abstract] |  |
ACCRUED LIABILITIES | NOTE 6. ACCRUED LIABILITIES As of September 30, 2024 and December 31, 2023, the accrued liabilities of the Company consisted of the following: SCHEDULE OF ACCRUED LIABILITIES
|  | September 30, 2024 |  |  | December 31, 2023 |
Product development |  | $ | 112,346 |  |  | $ | 139,981 |
Accrued salaries, wages, and bonuses |  |  | 8,736 |  |  |  | 8,889 |
Professional fees |  |  | 114,068 |  |  |  | 584,810 |
Accrued restructuring costs (see Note 9) |  |  | — |  |  |  | 301,645 |
Accrued franchise taxes |  |  | — |  |  |  | 22,318 |
Patent costs |  |  | 18,000 |  |  |  | 18,000 |
Total accrued expenses |  | $ | 253,150 |  |  | $ | 1,075,643 |
ENVERIC BIOSCIENCES, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS | NOTE 6. ACCRUED LIABILITIES As of December 31, 2023 and December 31, 2022, the accrued liabilities of the Company consisted of the following: SCHEDULE OF ACCRUED LIABILITIES
|  | December 31, 2023 |  |  | December 31, 2022 |
Product development |  | $ | 139,981 |  |  | $ | 195,104 |
Accrued salaries, wages, and bonuses |  |  | 8,889 |  |  |  | 1,175,963 |
Professional fees |  |  | 584,810 |  |  |  | 83,255 |
Accrued restructuring costs |  |  | 301,645 |  |  |  | — |
Accrued franchise taxes |  |  | 22,318 |  |  |  | — |
Patent costs |  |  | 18,000 |  |  |  | 251,333 |
Total accrued expenses |  | $ | 1,075,643 |  |  | $ | 1,705,655 |

X
- Definition The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(20)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(24)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 720 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(19)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration